These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 26614308)
1. What makes Cryptococcus gattii a pathogen? Bielska E; May RC FEMS Yeast Res; 2016 Feb; 16(1):fov106. PubMed ID: 26614308 [TBL] [Abstract][Full Text] [Related]
2. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Harris JR; Lockhart SR; Debess E; Marsden-Haug N; Goldoft M; Wohrle R; Lee S; Smelser C; Park B; Chiller T Clin Infect Dis; 2011 Dec; 53(12):1188-95. PubMed ID: 22016503 [TBL] [Abstract][Full Text] [Related]
3. Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest. Smith RM; Mba-Jonas A; Tourdjman M; Schimek T; DeBess E; Marsden-Haug N; Harris JR PLoS One; 2014; 9(2):e88875. PubMed ID: 24586423 [TBL] [Abstract][Full Text] [Related]
4. Emergence of Cryptococcus gattii-- Pacific Northwest, 2004-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(28):865-8. PubMed ID: 20651641 [TBL] [Abstract][Full Text] [Related]
6. The Disease Ecology, Epidemiology, Clinical Manifestations, and Management of Emerging Cryptococcus gattii Complex Infections. Diaz JH Wilderness Environ Med; 2020 Mar; 31(1):101-109. PubMed ID: 31813737 [TBL] [Abstract][Full Text] [Related]
7. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. Byrnes EJ; Bildfell RJ; Frank SA; Mitchell TG; Marr KA; Heitman J J Infect Dis; 2009 Apr; 199(7):1081-6. PubMed ID: 19220140 [TBL] [Abstract][Full Text] [Related]
8. Cryptococcosis due to Cryptococcus gattii in Germany from 2004-2013. Smith IM; Stephan C; Hogardt M; Klawe C; Tintelnot K; Rickerts V Int J Med Microbiol; 2015 Oct; 305(7):719-23. PubMed ID: 26341329 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil. Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450 [TBL] [Abstract][Full Text] [Related]
10. Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11. Gast CE; Basso LR; Bruzual I; Wong B Antimicrob Agents Chemother; 2013 Nov; 57(11):5478-85. PubMed ID: 23979758 [TBL] [Abstract][Full Text] [Related]
11. Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates. Lockhart SR; Iqbal N; Harris JR; Grossman NT; DeBess E; Wohrle R; Marsden-Haug N; Vugia DJ PLoS One; 2013; 8(9):e74737. PubMed ID: 24019979 [TBL] [Abstract][Full Text] [Related]
12. Emergence of Cryptococcus gattii--Pacific Northwest, 2004-2010. Center of Disease Control and Prevention Am J Transplant; 2011 Sep; 11(9):1989-92. PubMed ID: 21884409 [No Abstract] [Full Text] [Related]
13. Timing the Origin of Cryptococcus gattii sensu stricto, Southeastern United States. Lockhart SR; Roe CC; Engelthaler DM Emerg Infect Dis; 2018 Nov; 24(11):2095-2097. PubMed ID: 30334716 [TBL] [Abstract][Full Text] [Related]
14. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection. Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378 [TBL] [Abstract][Full Text] [Related]
15. Copy number variation contributes to cryptic genetic variation in outbreak lineages of Cryptococcus gattii from the North American Pacific Northwest. Steenwyk JL; Soghigian JS; Perfect JR; Gibbons JG BMC Genomics; 2016 Sep; 17(1):700. PubMed ID: 27590805 [TBL] [Abstract][Full Text] [Related]
16. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii. Chan M; Lye D; Win MK; Chow A; Barkham T Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090 [TBL] [Abstract][Full Text] [Related]
18. Ten challenges on Cryptococcus and cryptococcosis. Del Poeta M; Casadevall A Mycopathologia; 2012 Jun; 173(5-6):303-10. PubMed ID: 21948062 [TBL] [Abstract][Full Text] [Related]
19. Spatial Quantification of the Population Exposed to Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Europe: Estimating the Immunocompetent and HIV/AIDS Patients Under Risk. Alaniz AJ; Carvajal JG; Carvajal MA; Cogliati M; Vergara PM Risk Anal; 2020 Mar; 40(3):524-533. PubMed ID: 31578757 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008. Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]